David S. Shames
Center for Global Development(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, Lung Cancer Research Studies
Most-Cited Works
- → First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer(2018)3,394 cited
- → Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab(2018)1,185 cited
- → Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer(2012)1,088 cited
- → Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities(2021)886 cited
- → ctDNA guiding adjuvant immunotherapy in urothelial carcinoma(2021)584 cited
- → The mutation spectrum revealed by paired genome sequences from a lung cancer patient(2010)500 cited
- → Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy(2015)469 cited
- → Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer(2022)382 cited
- → Quantitative comparison of DNA methylation assays for biomarker development and clinical applications(2016)345 cited
- → Involvement of AGO1 and AGO2 in mammalian transcriptional silencing(2006)325 cited